A Study of Tolerability and Safety of Two New Doses of Grass MATA MPL

NCT02557633 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

29

Enrollment

INDUSTRY

Sponsor class

Conditions

Allergic Rhinitis

Interventions

BIOLOGICAL: Grass MATA MPL 10200
BIOLOGICAL: Grass MATA MPL 18200
BIOLOGICAL: Placebo

Sponsor

Allergy Therapeutics

Collaborators

[object Object]
[object Object]